| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EURHEARTJ/EHM177 |
| P698 | PubMed publication ID | 17576662 |
| P50 | author | Dirk J van Veldhuisen | Q82060328 |
| Adriaan A Voors | Q91537232 | ||
| Wiek H van Gilst | Q42159122 | ||
| P2093 | author name string | Erik Lipsic | |
| Pim van der Harst | |||
| Regien G Schoemaker | |||
| Peter van der Meer | |||
| B Daan Westenbrink | |||
| Hisko Oeseburg | |||
| Gideon J Du Marchie Sarvaas | |||
| Johan Koster | |||
| P433 | issue | 16 | |
| P921 | main subject | erythropoietin | Q218706 |
| neovascularization | Q1281049 | ||
| P304 | page(s) | 2018-2027 | |
| P577 | publication date | 2007-06-17 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization | |
| P478 | volume | 28 |
| Q34610877 | A multicenter, prospective, randomized, controlled trial evaluating the safety and efficacy of intracoronary cell infusion mobilized with granulocyte colony-stimulating factor and darbepoetin after acute myocardial infarction: study design and ratio |
| Q42923034 | A single dose of erythropoietin in ST-elevation myocardial infarction |
| Q42159077 | AKIP1, a cardiac hypertrophy induced protein that stimulates cardiomyocyte growth via the Akt pathway |
| Q34058253 | Aging, telomeres and heart failure |
| Q49375977 | Alternative Erythropoietin Receptors in the Nervous System |
| Q41943331 | An emerging need for developing new models for myocardial infarction as a chronic complex disease: lessons learnt from animal vs. human studies on cardioprotective effects of Erythropoietin in reperfused myocardium |
| Q35252704 | Anemia and heart failure: a cause of progression or only a consequence? |
| Q37883005 | Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches |
| Q37258782 | Anemia and the potential role of erythropoiesis-stimulating agents in heart failure |
| Q48227787 | Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease. |
| Q39389842 | Angiogenic growth factors in myocardial infarction: a critical appraisal |
| Q37130139 | Approaches to the treatment of anaemia in patients with chronic heart failure |
| Q26765959 | Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms |
| Q38164335 | Cardiac regeneration: current therapies-future concepts |
| Q37533151 | Cardiovascular Effects of Erythropoietin |
| Q37783940 | Clinical Application of Stem Cells in the Cardiovascular System |
| Q30491515 | Combined intermittent hypoxia and surface muscle electrostimulation as a method to increase peripheral blood progenitor cell concentration |
| Q46610002 | Cytokine Combination Therapy With Long-Acting Erythropoietin and Granulocyte Colony Stimulating Factor Improves Cardiac Function But is Not Superior Than Monotherapy in a Mouse Model of Acute Myocardial Infarction |
| Q37038709 | Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure |
| Q42566367 | Distribution of cardiac stem cells in the human heart |
| Q37072564 | Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure? |
| Q33558915 | EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy |
| Q38307569 | Echocardiographic Evaluation of the Effects of a Single Bolus of Erythropoietin on Reducing Ischemia-Reperfusion Injuries during Coronary Artery Bypass Graft Surgery; A Randomized, Double-Blind, Placebo-Control Study |
| Q57796291 | Effect of Erythropoietin Administration on Myocardial Viability and Coronary Microvascular Dysfunction in Anterior Acute Myocardial Infarction: Randomized Controlled Trial in the Japanese Population |
| Q53209507 | Effects of erythropoietin on angiogenesis after myocardial infarction in porcine. |
| Q33726150 | Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial |
| Q36636749 | Endothelial Progenitor Cells Predict Long-Term Mortality in Hemodialysis Patients |
| Q41810175 | Endothelial progenitor cells homing and renal repair in experimental renovascular disease |
| Q40025021 | Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age. |
| Q24240277 | Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients |
| Q24241045 | Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients |
| Q37098040 | Erythropoietic agents and the elderly |
| Q37833828 | Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models |
| Q37781871 | Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword? |
| Q36002233 | Erythropoietin Attenuates Pulmonary Vascular Remodeling in Experimental Pulmonary Arterial Hypertension through Interplay between Endothelial Progenitor Cells and Heme Oxygenase |
| Q28748456 | Erythropoietin Improves the Survival of Fat Tissue after Its Transplantation in Nude Mice |
| Q35705440 | Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction |
| Q41261940 | Erythropoietin Stimulates Endothelial Progenitor Cells to Induce Endothelialization in an Aneurysm Neck After Coil Embolization by Modulating Vascular Endothelial Growth Factor |
| Q39432541 | Erythropoietin and Its Angiogenic Activity |
| Q34783442 | Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells |
| Q36944477 | Erythropoietin and oxidative stress |
| Q42755181 | Erythropoietin and ventricular remodelling: a VEGF-dependent neovascularity |
| Q41939381 | Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats |
| Q35909929 | Erythropoietin in brain development and beyond |
| Q90701568 | Erythropoietin in tumor angiogenesis |
| Q37326950 | Erythropoietin signaling promotes transplanted progenitor cell survival |
| Q41199630 | Erythropoietin stimulates the coronary collateral development in patients with coronary chronic total occlusion. |
| Q34100489 | Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system |
| Q36740470 | Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies |
| Q37157213 | Exercise training and peripheral arterial disease |
| Q83422958 | Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice |
| Q85118913 | G-CSF and erythropoietin combination therapy for infarct repair: two plus two equals two? Editorial to: "Cytokine combination theray with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction" by |
| Q34663709 | Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin |
| Q37871920 | Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond |
| Q41120104 | Homing of stem cells to ischemic myocardium |
| Q46323076 | Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization |
| Q53049445 | Imaging of cardiac and renal perfusion in a rat model with 13N-NH 3 micro-PET. |
| Q33792006 | Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease. |
| Q53052916 | In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET. |
| Q41882175 | Increased cardiovascular risk in rats with primary renal dysfunction; mediating role for vascular endothelial function |
| Q42824239 | Management of Anemia and Iron Deficiency in Heart Failure |
| Q36484420 | Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms |
| Q37295247 | Migration of bone marrow-derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarction |
| Q37254556 | Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing. |
| Q40776947 | Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure |
| Q41214335 | Promises and pitfalls in cell replacement therapy for heart failure |
| Q36664578 | Raves and risks for erythropoietin |
| Q43044445 | Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al." |
| Q36311539 | Recombinant human erythropoietin improves the neurofunctional recovery of rats following traumatic brain injury via an increase in circulating endothelial progenitor cells |
| Q41991979 | Recombinant human erythropoietin increases cerebral cortical width index and neurogenesis following ischemic stroke |
| Q43251940 | Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 2: Pharmacological targets, agents and intervention perspectives |
| Q36655932 | Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study |
| Q33595290 | Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products |
| Q34470451 | Simultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesis |
| Q28069300 | Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet? |
| Q34725972 | Survival and proliferative roles of erythropoietin beyond the erythroid lineage |
| Q33572237 | Telomere biology in healthy aging and disease |
| Q37024848 | The case for statin therapy in chronic heart failure |
| Q36947417 | Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond |
| Q41836951 | Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium. |
Search more.